Myriad Genetics | MYGN - Interest Expense On Debt


Myriad Genetics reported $4.4M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Agilent USD 25M 2M Dec/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Bio-Rad Laboratories USD 12.3M 100K Sep/2025
Bruker USD 20M 4.3M Sep/2025
Danaher USD 55M 12M Dec/2025
Hologic USD 27.6M 1000K Dec/2025
Illumina USD 25M 0 Sep/2025
J&J USD 18M 290M Sep/2025
Mettler Toledo International USD 17.39M 307K Dec/2025
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Quest Diagnostics USD 69M 2M Sep/2025
Quidel USD 5.68B 5.63B Sep/2025
Repligen USD 5.5M 81K Dec/2025
Revvity USD 23.51M 742K Dec/2025
Standard Biotools USD 5K 5K Dec/2025
Thermo Fisher Scientific USD 365M 18M Dec/2025
Veracyte USD 2K 1000 Dec/2023
Waters USD 8.62M 18.02M Dec/2025